Kristiina Vuori M.D., Director at Inhibrx Biosciences, Inc. (INBX), bought 6,667 shares at $15.00 ($100K) on 2024-10-03, disclosed to the SEC on 2024-10-07.
Open-market purchase of $100k INBX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| WBMD | SELL | 2016-12-13 | $144K | — | Filing → |